Novare Surgical Systems, founded eight years ago to improve upon the Fogarty Clamp and now emerging from a discouraging five-year slump, is finding success--but in an entirely different business. In developing next generation laparoscopic tools, Novare executives believe they’re introducing a paradigm shift.
By Tom Salemi
Tom Fogarty had his name on the products, and even he knew it was time to move on.
Join thousands of industry professionals who rely on In Vivo for daily insights
Already a subscriber?
Bristol Myers Squibb executive Doxie Jordan discusses his path to global commercial leadership and the principles guiding pharmaceutical market strategy
Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and improve overall access to nondrug interventions like CST.
In a challenging funding environment for biopharma, strategic dealmaking has become a critical growth engine. In Vivo explores what it truly takes to navigate high-stakes acquisitions and partnerships, drawing on insights from seasoned industry leaders.
